AANA Journal: Bupivacaine Dosing for Cesarean Delivery in Parturients of Short Stature: A Retrospective Case-Control Study-AANA Journal: Bupivacaine Dosing for Cesarean Delivery in Parturients of Short Stature: A Retrospective Case Control Study

AANA Journal: Bupivacaine Dosing for Cesarean Delivery in Parturients of Short Stature: A Retrospective Case Control Study

Back to course

Pdf Summary

The study investigated the dosing of intrathecal bupivacaine for cesarean delivery in parturients of short stature compared to those of normal stature. The research, conducted over a 10-year period, found that parturients of short stature were administered significantly lower doses of bupivacaine without an increase in adverse outcomes. The dosing of spinal bupivacaine remains a challenge for anesthesia providers, with the study suggesting that a modest reduction in dose might be appropriate for parturients of short stature. The study aimed to address the gap in literature, as previous studies often excluded extreme heights, leading to uncertainty in dosing strategies. The findings indicated that height and weight did not significantly affect spinal blockade, challenging previous beliefs. However, the study acknowledges its limitations, primarily due to its retrospective design and small sample size, recommending future dose-finding studies focusing on extremes of maternal height. Overall, the research contributes valuable insights into anesthesia dosing considerations for parturients of short stature undergoing cesarean delivery.

Keywords

intrathecal bupivacaine dosing

cesarean delivery

parturients

short stature

normal stature

spinal bupivacaine dosing

anesthesia providers

maternal height

dose-finding studies

adverse outcomes